Movement Alert|Aehr Test Rises 8.68% in Regular Trading, Jefferies Initiates Coverage With Buy Rating and $175 Target Price

Market Focus
Aug 14

On August 14, Aehr Test rose 8.68% in regular trading, trading at $138.20 USD/share, with turnover of $36.07 million. The stock gained momentum following a significant analyst initiation earlier in the session.

On the news front, investment bank Jefferies initiated coverage of Aehr Test Systems with a \"Buy\" rating and a $175 price target, substantially above the prior analyst consensus target of $127. The $175 target implies approximately 31% upside from current levels, significantly boosting market sentiment toward the stock.

The initiation comes amid a series of positive catalysts. On August 12, the company disclosed a $22 million follow-on production order from its lead wafer-level AI processor customer, covering multiple fully automated FOX-XP systems expected to ship within six months to a high-volume manufacturing partner in Taiwan. The company's business structure has undergone a major transformation — AI data center-related business is projected to account for approximately 70% of fiscal year 2027 revenue, up from near-zero two years ago when electric vehicle silicon carbide dominated over 95% of sales. Jefferies' high-conviction initiation further reinforces market expectations for sustained growth in the AI test equipment segment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10